Nasal Decongestant Tablet, Film Coated
Product Images NDC 59779-432

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nasal Decongestant (NDC 59779-432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cvs Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cvs Health Nasal Decongestant (03 06 17 4326217c4 B)

Cvs Health Nasal Decongestant (03 06 17 4326217c4 B)
Drug Facts panel for Nasal Decongestant tablets containing Pseudoephedrine HCl 30 mg. Includes active ingredient purpose, uses, warnings, dosage instructions for different age groups, inactive ingredients, storage information, and contact details for questions or comments. Distributed by CVS Pharmacy.*
FDA Label Image

Cvs Health Nasal Decongestant (03 06 17 4326217c4 F)

Cvs Health Nasal Decongestant (03 06 17 4326217c4 F)
Packaging label for CVS Health Nasal Decongestant tablets, each containing 30 mg of pseudoephedrine hydrochloride. The label highlights the product as non-drowsy and maximum strength, with 24 tablets per package. It includes a depiction of the tablet size and a red heart graphic, with comparison to an active ingredient in Sudafed Congestion noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.